🇺🇸 FDA

Company profile · Sponsor

Second

Second Xiangya Hospital of Central South University

CC79424 · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Second (CC79424) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CC79424
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. Rivaroxaban 2.5 mg

    Second

    Acute Coronary Syndrome

    approved small molecule completed

    1 trial

Frequently asked questions

What is Second?

Second (CC79424) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Second sponsor?

We track 1 ClinicalTrials.gov-linked program for Second, including Rivaroxaban 2.5 mg. Open each program for phase, modality, NCT IDs, and indication details.

Where does Second company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.